Slowing or Delaying Vision Loss in Retinitis Pigmentosa (USH2A gene mutation subtype)

active 🌍 Public

Retinitis Pigmentosa (RP) caused by USH2A mutations is a progressive retinal degenerative disease leading to gradual vision loss and potential blindness. Currently, there is no widely available cure. The goal is to identify, evaluate, and track approaches that can: - Slow disease progression - Preserve photoreceptor function - Improve or compensate visual capability - Extend useful vision duration

Rare Disease / Ophthalmology by RPResearcher 2026-04-06 Knowledge Memory
This is a thinking workspace. The goal is not to collect information, but to refine understanding and make better decisions.
Hypotheses 5
Contributions 4
Knowledge 0
Evidence 10
Open Questions 0
Last Activity 2026-06-13 22:19

Current State

No state snapshot yet. Capture the current state of this problem.

Edit state snapshot

Research Brief

Current Understanding

No summary yet.

Most Promising Directions

None identified yet.

Open Unknowns

None listed yet.

Edit research brief

Where to Help

🧪
Weakly Supported Hypothesis
Lifestyle and Environmental Factors Affect Progression

0 supports, 0 weakens — needs validation

🧪
Weakly Supported Hypothesis
Pharmacological Treatments Can Slow Degeneration

0 supports, 0 weakens — needs validation

🧪
Weakly Supported Hypothesis
Gene Therapy Can Slow or Stop Progression

1 supports, 0 weakens — needs validation

🔍
Unexplored Hypothesis
Assistive Technologies Can Extend Functional Vision

No contributions yet

🔍
Unexplored Hypothesis
Cell-Based Therapies Can Restore Function

No contributions yet

Recent Activity

•
Problem state snapshot updated by anonymous
06/13 22:19
B
Research brief updated by anonymous
06/13 22:19
✓
Open question resolved: "What factors most strongly influence progression speed in USH2A RP?" by anonymous
06/13 22:19
✓
Open question resolved: "Are any treatments effective specifically for USH2A mutations (vs. general RP)?" by anonymous
06/13 22:19
✓
Open question resolved: "Which therapies are closest to real-world availability for USH2A RP?" by anonymous
06/13 22:19
✓
Open question resolved: "What are the cost and accessibility barriers for future treatments?" by anonymous
06/13 22:19
✓
Open question resolved: "What is the long-term outlook for emerging gene/RNA therapies?" by anonymous
06/13 22:19
✓
Open question resolved: "What is the natural history of vision loss in USH2A RP specifically?" by anonymous
06/13 22:19
✓
Open question resolved: "How effective are current assistive technologies for RP patients?" by anonymous
06/13 22:19
✓
Open question resolved: "What is the risk-benefit profile of Vitamin A supplementation for USH2A RP?" by anonymous
06/13 22:19

Hypothesis Tree

Compare Hypotheses AI Suggest Hypotheses AI Build Hypothesis + Add Hypothesis
Gene Therapy Can Slow or Stop Progression exploring Leading hypothesis
confidence: 45%
Supports 1 Weakens 0 Explores 1 Neutral 0
2 contributions 0 evidence updated 04/06

Most actively researched direction. Multiple clinical trials ongoing. Key challenge is USH2A gene si...

supports Are there active clinical trials for USH2A RP? 04/06
explores Can antisense oligonucleotide therapy help USH2A RP? 04/06
Lifestyle and Environmental Factors Affect Progression exploring
confidence: 35%
Supports 0 Weakens 0 Explores 1 Neutral 0
1 contribution 1 evidence updated 04/06

Some animal model evidence for light exposure effects. Dietary influence is plausible but not well q...

explores Can light exposure accelerate retinal degeneration in RP? 04/06
Pharmacological Treatments Can Slow Degeneration exploring
confidence: 30%
Supports 0 Weakens 0 Explores 1 Neutral 0
1 contribution 0 evidence updated 04/06

Mixed evidence. Some historical support for Vitamin A but with safety concerns. Neuroprotective agen...

explores Does Vitamin A slow RP progression? 04/06
Assistive Technologies Can Extend Functional Vision exploring
confidence: 60%
Supports 0 Weakens 0 Explores 0 Neutral 0
0 contributions 0 evidence updated 04/06

Most immediately actionable. Low-vision aids are available now. Retinal prosthetics and AI vision ar...

Cell-Based Therapies Can Restore Function exploring
confidence: 25%
Supports 0 Weakens 0 Explores 0 Neutral 0
0 contributions 0 evidence updated 04/06

Promising long-term but still largely experimental. Integration of transplanted cells remains a chal...

Evidence & Resources

AI Collect Evidence + Add Evidence
observation (1)
observation user

Vision changes correlate with seasonal light exposure

Personal observation over 2 years

1 linked by RPResearcher
04/06
note (2)
note user

Patient experiences with low-vision aids

Reports from RP community on effectiveness of assistive tools.

by RPResearcher
04/06
note user

Patient community discussion: supplement experiences

Collected experiences from Foundation Fighting Blindness forum on Vitamin A, lutein, and omega-3 supplementation.

by RPResearcher
04/06
dataset (3)
dataset user

jCyte stem cell therapy trial for RP

Phase 2 trial of human retinal progenitor cell therapy for RP patients.

link by RPResearcher
04/06
dataset user

Editas Medicine CRISPR-based gene editing for retinal disease

Early-stage trial exploring CRISPR delivery to retinal cells.

link by RPResearcher
04/06
dataset user

ProQR QR-421a Phase 2/3 trial for USH2A exon 13

Active clinical trial testing AON-based exon skipping for USH2A patients with exon 13 mutations.

link by RPResearcher
04/06
paper (4)
paper user

Neuroprotective strategies for retinitis pigmentosa: a systematic review

Evaluation of pharmacological neuroprotection approaches across RP subtypes.

link by RPResearcher
04/06
paper user

Retinal degeneration pathways in Usher syndrome type 2

Molecular pathways leading to photoreceptor death in USH2A-related conditions.

link by RPResearcher
04/06
paper user

Antisense oligonucleotide therapy for inherited retinal diseases

Overview of AON approaches including exon-skipping strategies for large genes like USH2A.

link by RPResearcher
04/06
paper user

USH2A mutation mechanisms and structural protein dysfunction

Review of how USH2A mutations affect usherin protein and photoreceptor cell structure.

link by RPResearcher
04/06
Browse all 10 evidence items

Open Questions

No open questions yet.

Record what is currently blocking progress or needs investigation.

Add a question

Recent Contributions

+ Add Contribution
explores

Can light exposure accelerate retinal degeneration in RP?

Protective strategies (e.g., UV-blocking sunglasses, reducing screen brightness) may be low-risk interventions worth rec...

04/06
supports

Are there active clinical trials for USH2A RP?

The field is active and well-funded, but most therapies are still experimental. No treatment has yet reached Phase 3 app...

04/06
explores

Does Vitamin A slow RP progression?

Potential benefit is uncertain and may depend on dosage and patient profile. Risk-benefit balance is unclear, especially...

04/06
explores

Can antisense oligonucleotide therapy help USH2A RP?

Mutation-specific therapies may be promising but not universally applicable. Different USH2A mutations may require diffe...

04/06

Knowledge Base

+ Add Item

No knowledge items yet.

Add papers, datasets, or notes that support this research.